Clinical trial
Niclosamide for Patients With Mild to Moderate Disease From Novel Coronavirus (COVID-19)
NCT04399356 is registered in ClinicalTrials.gov with Tufts Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Niclosamide for Patients With Mild to Moderate Disease From Novel Coronavirus (COVID-19)
- Lead sponsor
- Tufts Medical Center
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- October 1, 2020
- Completion date
- August 19, 2021
- Enrollment
- 73 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.